The financials
Xenon Pharmaceuticals Inc. by the numbers
Xenon Pharmaceuticals Inc. (XENE) reported revenue of $0 in Q1 2026 (quarter ended March 31, 2026), down 100% from the same quarter a year earlier. That came with net loss of $102M. For the full year FY2025, revenue was $7.5M and net income −$346M.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $0 | $7.5M | to a loss |
| Operating income | −$112M | −$73M | n/a |
| Net income | −$102M | −$65M | n/a |
| Diluted EPS | −$1.17 | −$0.83 | n/a |